Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
Recruiting in Palo Alto (17 mi)
+2 other locations
DL
Overseen byDhanunjaya Lakkireddy, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Kansas City Heart Rhythm Research Foundation
No Placebo Group
Trial Summary
What is the purpose of this trial?
This study is intended to assess the incidence and correlation to the development of peri-device leaks (PDLs), device related thrombosis (DRTs) and cerebral vascular accident (CVA)/transient ischemic attacks (TIAs) in association with left atrial appendage contrast flow (LAA-CF). It will be a multi-center, retrospective study. Approximately 100 subject charts will be reviewed.
Research Team
DL
Dhanunjaya Lakkireddy, MD
Principal Investigator
Kansas City Heart Rhythm Institute
Eligibility Criteria
Inclusion Criteria
You are 18 years of age or older.
Subjects underwent LAA occlusion utilizing either Watchman/Watchman FLX or Amplatzer Amulet at our facility between January 2019 and June 2022.
Treatment Details
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Watchman / Watchman FLXExperimental Treatment1 Intervention
This is the group of subjects who are implanted with Watchman / Watchman FLX device.
Group II: Amplatzer AmuletExperimental Treatment1 Intervention
This is the group of subjects who are implanted with Amplatzer Amulet device.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kansas City Heart Rhythm Research Foundation
Lead Sponsor
Trials
30
Recruited
14,000+